Results 281 to 290 of about 22,236,668 (323)
Some of the next articles are maybe not open access.
Management of hepatorenal syndrome and treatment-related adverse events
Current Medical Research and OpinionHepatorenal Syndrome is a critical complication of liver failure, mainly in cirrhotic patients and rarely in patients with acute liver disease. It is a complex spectrum of conditions that leads to renal dysfunction in the liver cirrhosis population; the ...
Lorenzo Peluso +8 more
semanticscholar +3 more sources
Treatment Related Adverse Events in Chemotherapy and Their Intervention
International Journal of Clinical Studies and Medical Case Reports, 2021S. Aldossary
semanticscholar +2 more sources
The Lancet Oncology, 2023
BACKGROUND Incorporating immune checkpoint blockade into perioperative cancer therapy has improved clinical outcomes. However, the safety of immune checkpoint blockade needs better evaluation, given the chances of more prolonged disease-free survival. We
Yu Fujiwara +7 more
semanticscholar +1 more source
BACKGROUND Incorporating immune checkpoint blockade into perioperative cancer therapy has improved clinical outcomes. However, the safety of immune checkpoint blockade needs better evaluation, given the chances of more prolonged disease-free survival. We
Yu Fujiwara +7 more
semanticscholar +1 more source
Immunotherapy, 2023
Introduction: Combined immune checkpoint inhibitors can cause gastrointestinal adverse events. Methods: We performed a meta-analysis of pooled colonic, hepatic and pancreatic treatment-related adverse events of combined ICI. Results: 53 trials reporting treatment-related adverse events in 6581 patients.
Rahul Karna +13 more
openaire +2 more sources
Introduction: Combined immune checkpoint inhibitors can cause gastrointestinal adverse events. Methods: We performed a meta-analysis of pooled colonic, hepatic and pancreatic treatment-related adverse events of combined ICI. Results: 53 trials reporting treatment-related adverse events in 6581 patients.
Rahul Karna +13 more
openaire +2 more sources
Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
European Journal of Cancer, 2021INTRODUCTION With the increasing use of checkpoint inhibitors, rare immune-related adverse events (irAE) are being identified. Haematological irAE (hem-irAE) are difficult to treat and have shown high mortality rates.
Rafaela Kramer +32 more
semanticscholar +1 more source
Management of treatment-related adverse events in patients with multiple myeloma
Cancer Treatment Reviews, 2010The introduction of novel antimyeloma therapies, including thalidomide, lenalidomide and bortezomib, has expanded treatment options for patients with multiple myeloma. These compounds alter the natural history of multiple myeloma and help improve outcomes, but have different and specific toxicity profiles. The major adverse events associated with these
openaire +2 more sources
Risk factors for treatment‐related adverse events in cancer‐bearing dogs receiving piroxicam
Veterinary and Comparative Oncology, 2016AbstractPiroxicam has antitumour effects in dogs with cancer, although side effects may limit its use. The purpose of this study was to retrospectively identify factors predisposing cancer‐bearing dogs to adverse events (AEs) following piroxicam therapy.
L R, Eichstadt +2 more
openaire +2 more sources
Psychiatry Research, 2004
The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg).
George I, Papakostas +5 more
openaire +2 more sources
The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg).
George I, Papakostas +5 more
openaire +2 more sources
Annals of Clinical Psychiatry, 2003
Treatment-related adverse events (TRAEs), particularly those that occur early on, may increase the likelihood for premature discontinuation of antidepressants. The purpose of this study was to examine the relationship between TRAEs and outcome in depressed outpatients enrolled in an 8-week, 20 mg, open trial of fluoxetine. A total of 384 patients (54.7%
George I, Papakostas +6 more
openaire +2 more sources
Treatment-related adverse events (TRAEs), particularly those that occur early on, may increase the likelihood for premature discontinuation of antidepressants. The purpose of this study was to examine the relationship between TRAEs and outcome in depressed outpatients enrolled in an 8-week, 20 mg, open trial of fluoxetine. A total of 384 patients (54.7%
George I, Papakostas +6 more
openaire +2 more sources

